QLINEA fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Q-linea AB operates as a holding company. The firm engages in the development of inventive systems for in vitro diagnostics for infectious diseases. Its products include ASTar, ASTrID and Data. The company was founded by Jonas Sven Peter Jarvius, Bernitz Mats Bo Johan Nilsson, Jan Grawe and Johan Stenberg in April 2008 and is headquartered in Uppsala, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
QLINEA does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company